Dr. Steffen Oppenländer

Primary Focus & Experience

He represents private equity and corporate clients on complex domestic and cross-border acquisitions, public takeovers, minority investments and joint ventures. Steffen Oppenländer is Managing Partner of the Munich office.

Selected Projects

• Hg Capital on their co-investment in GGW Group GmbH.
• Bain Capital on acquisition of Wittur Group and Wittur on acquisition of Sematic Group.
• CVC Capital on sale of Flint Group.
• EQT X on the public takeover of va-Q-tec.
• EQT IX on the public takeover and take private of zooplus.
• EQT IX on the acquisition of thinkproject.
• EQT VIII on the acquisition of SUSE and SUSE on the subsequent acquisition of Rancher.
• EQT Future on the acquisition of Anticimex.
• EQT Mid Market on the sale of kfzteile24 and the sale of BBS Automation.
• Founder of SHL Medical on the sale of a minority participation to EQT.
• Moonfare on capital investments by Fidelity and Insight Partners.
• OTPP and PAI on the acquisition of Veonet.
• PAI on the acquisition of zahneins.
• TenneT on the acquisition of German extra high voltage transmission system, the NordLink interconnector JV with KfW and Statnett as well as the DolWin3 HVDC connection JV with CIP.

Recognition & Accomplishments

Steffen Oppenländer is recognized as one of the leading lawyers in Germany for private equity and M&A, including by directories JUVE, Chambers and Legal 500.

Steffen studied law at the Universities of Freiburg and Munich. He has a doctorate in law from the University of Bonn. Steffen was admitted to the German bar in 2003. He speaks German and English.